Volver a Noticias

Ingredient news

Echinacea Catalog Update Shows Why EU Ingredient Identity Needs Scope

By Nutranexa News |

NutraIngredients reported an EU Novel Food Catalog update on Echinacea and continuing uncertainty around flowers, whole-plant preparations, and species scope.

European regulatory reviewer comparing botanical source trays with blank novel-food scope cards and a supplement dossier

Nutranexa generated image

What Was Reported

NutraIngredients reported that the EU confirmed traditional Echinacea roots, herbs, and teas as non-novel while uncertainty remained around flowers, whole-plant preparations, and Echinacea pallida. The report emphasizes that a common ingredient name may cover materially different preparations.

The same identity principle matters for phosphatidylserine. Soy PS, sunflower PS, different assay grades, carriers, and processing routes should not be treated as interchangeable simply because a short name appears on a quotation.

Ingredient Buyer Context

European regulatory reviewer comparing botanical source trays with blank novel-food scope cards and a supplement dossier with a closer quality-review detail

When preparing an EU PS file, record source, composition, production route, intended use, and the exact legal question. If a buyer is assessing a novel-food or food-supplement route, keep the current specification and regulatory rationale tied to the product rather than relying on a broad ingredient label.

The source concerns the named study, company, agency, or market development. It should not be expanded into a medical treatment claim, a universal ingredient result, or a guarantee about a supplier or finished product.

Nutranexa Takeaway

The Echinacea update does not determine the status of Nutranexa PS. Buyers should confirm the current EU route for the exact ingredient and intended application with their responsible regulatory team.

For a product-specific discussion, provide the target market, application, source preference, PS grade, annual quantity, packaging, and required documents. Nutranexa can then discuss the relevant product and quality evidence without assuming facts that are not in the current controlled file.

Fuentes